{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:22:25Z","timestamp":1785817345968,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Neurosurg Jl"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Moyamoya disease (MMD), also known as spontaneous occlusion of the circle of Willis, is defined by progressive stenosis or occlusion of the internal carotid arteries, and it can progress to the anterior, middle, and posterior cerebral arteries. As these arteries are gradually stenosed, a collateral network of capillaries develops at the base of the brain, producing the characteristic reticulate appearance (\u201cpuff of smoke\u201d) on angiography. Therefore, it was named by Suzuki and Takaku in 1969 after the Japanese term \u201cmoyamoya\u201d (Suzuki and Takaku, Arch Neurol 20:288\u2013299, 1969). MMD is most common in East Asian countries such as Japan and Korea, and it shows a slight female predominance. MMD is mainly characterized by ischemia and hemorrhage. Hemorrhagic MMD is very rare in children, and most cases occur in adults due to the rupture of the compensatory blood vessels, which often leads to hemorrhagic symptoms (Scott and Smith, N Engl J Med 360:1226\u20131237, 2009). In recent years, the diagnosis rate has increased with the popularization of imaging techniques. However, the pathogenesis of MMD is still not completely understood, and there is currently no evidence to suggest that drug treatment can delay or even reverse the progression of MMD. The current drug treatment for in MMD only targets its clinical symptoms, including ischemia and hemorrhage. The main choice of treatment for MMD is surgical revascularization. As an increasing number of hospitals have developed surgical treatment for MMD, our compiling group has jointly discussed the formulation of a consensus among Chinese experts on the treatment of MMD.<\/jats:p>","DOI":"10.1186\/s41016-023-00318-3","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:04:10Z","timestamp":1677143050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chinese expert consensus on the treatment of MMD"],"prefix":"10.1186","volume":"9","author":[{"given":"Xiang-Yang","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"318_CR1","unstructured":"Chen Jie, Gao Shan, Hu Yinghuan. Preliminary observation on the relationship between microembolic signals and clinical manifestations and infarcts in patients with moyamoya disease. Chin J Stroke, 2012;7(7):531-536"},{"key":"318_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000083246","volume":"19","author":"P Horn","year":"2005","unstructured":"Horn P, Lanczik O, Vajkoczy P, et al. Hemodynamic reserve and high-intensity transient signals in moyamoya disease. Cerebrovasc Dis. 2005;19:141\u20136.","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"318_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.003","volume":"25","author":"S Yamada","year":"2016","unstructured":"Yamada S, Oki K, Itoh Y, Kuroda S, Houkin K, Tominaga T, Miyamoto S, Hashimoto N, Suzuki N, Research Committee on Spontaneous Occlusion of Circle of Willis (Moyamoya Disease). Effects of surgery and antiplatelet therapy in ten-year follow-up from the registry study of research committee on moyamoya disease in Japan. J Stroke Cerebrovasc Dis. 2016;25(2):340\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"318_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/ene.12392","volume":"21","author":"J Chen","year":"2014","unstructured":"Chen J, Duan L, Xu WH, et al. Microembolic signals predict cerebral ischaemic events in patients with moyamoya disease. Eur J Neurol. 2014;21:785\u201390.","journal-title":"Eur J Neurol"},{"key":"318_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"HC Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331\u20137.","journal-title":"Lancet"},{"key":"318_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52:245\u201366.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"318_CR7","doi-asserted-by":"publisher","first-page":"e009942","DOI":"10.1136\/bmjopen-2015-009942","volume":"6","author":"D Onozuka","year":"2016","unstructured":"Onozuka D, Hagihara A, Nishimura K, Kada A, Nakagawara J, Ogasawara K, Ono J, Shiokawa Y, Aruga T, Miyachi S, Nagata I, Toyoda K, Matsuda S, Suzuki A, Kataoka H, Nakamura F, Kamitani S, Nishimura A, Kurogi R, Sayama T, Iihara K, J-ASPECT Study Collaborators. Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study). BMJ Open. 2016;6(3).","journal-title":"BMJ Open"},{"issue":"11","key":"318_CR8","first-page":"1275","volume":"29","author":"Li Tao","year":"2014","unstructured":"Tao Li. Therapeutic effect of troxerutin brain protein hydrolyzate injection combined with aspirin enteric-coated tablets on moyamoya disease. Mod Drug Clin. 2014;29(11):1275\u20138.","journal-title":"Mod Drug Clin"},{"issue":"2","key":"318_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2014.12.014","volume":"238","author":"E Oikonomou","year":"2015","unstructured":"Oikonomou E, Siasos G, Zaromitidou M, et al. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients. Atherosclerosis. 2015;238(2):159\u201364.","journal-title":"Atherosclerosis"},{"issue":"1","key":"318_CR10","first-page":"10","volume":"5","author":"Bu Sun Yanxi","year":"2015","unstructured":"Sun Yanxi Bu, Xingyao YQ, et al. Clinical study of combined revascularization combined with simvastatin in the treatment of ischemic moyamoya disease. Chin J Brain Dis Rehabil (Electronic Edition). 2015;5(1):10\u20134.","journal-title":"Chin J Brain Dis Rehabil (Electronic Edition)"},{"issue":"7","key":"318_CR11","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/STROKEAHA.116.013304","volume":"47","author":"H Uchino","year":"2016","unstructured":"Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K. Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke. 2016;47(7):1930\u20132.","journal-title":"Stroke"},{"key":"318_CR12","first-page":"1","volume":"15","author":"Z Li","year":"2019","unstructured":"Li Z, Lu J, Ma L, Wu C, Xu Z, Chen X, Ye X, Wang R, Zhao Y. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis. J Neurosurg. 2019;15:1\u201313.","journal-title":"J Neurosurg"},{"issue":"4","key":"318_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/bc.bc_30_17","volume":"3","author":"S Li","year":"2017","unstructured":"Li S, Zhao W, Han C, Rajah GB, Ren C, Xu J, Shang S, Meng R, Ding Y, Ji X. Safety and efficacy of remote ischemic conditioning in pediatric moyamoya disease patients treated with revascularization therapy. Brain Circ. 2017;3(4):213\u20138.","journal-title":"Brain Circ"},{"key":"318_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1161\/01.STR.27.8.1342","volume":"27","author":"K Houkin","year":"1996","unstructured":"Houkin K, Kamiyama H, Abe H, et al. Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke. 1996;27:1342\u20136.","journal-title":"Stroke"},{"key":"318_CR15","first-page":"463","volume":"49","author":"S Kuroda","year":"2001","unstructured":"Kuroda S, Houkin K, Kamiyama H, et al. Effects of surgical revascularization on peripheral artery aneurysms in moyamoya disease: report of three cases. Neurosurgery. 2001;49:463\u20138.","journal-title":"Neurosurgery"},{"key":"318_CR16","unstructured":"Karasawa J, Hosoi K, Morisako T. [Revascularization for hemorrhagic Moyamoya disease], in: [Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health, Labour and Welfare Annual Report 2000] (Japanese). 2001, pp55\u201358."},{"key":"318_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3171\/jns.2000.93.3.0397","volume":"93","author":"S Kawaguchi","year":"2000","unstructured":"Kawaguchi S, Okuno S, Sakaki T. Effect of direct ar-terial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg. 2000;93:397\u2013401.","journal-title":"J Neurosurg"},{"key":"318_CR18","first-page":"416","volume":"32","author":"I Nakagawa","year":"2004","unstructured":"Nakagawa I, Kawaguchi S, Iida J, et al. [Direct bypass of STA-MCA anastomosis prevents future stroke in patients with the hemorrhagic type of moyamoya disease] (Japanese). No Socchu No Geka. 2004;32:416\u201320.","journal-title":"No Socchu No Geka"},{"issue":"Suppl 2","key":"318_CR19","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1016\/S0303-8467(97)00078-4","volume":"99","author":"K Fujii","year":"1997","unstructured":"Fujii K, Ikezaki K, Irikura K, et al. The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg. 1997;99(Suppl 2):S194-195.","journal-title":"Clin Neurol Neurosurg"},{"key":"318_CR20","first-page":"463","volume":"20","author":"S Suzuki","year":"1992","unstructured":"Suzuki S, Maeyama R, Nagatomi H, et al. [Surgical treatment for adult patients with moyamoya disease. With special reference to hemorrhagic type] (Japanese). No Socchu No Geka. 1992;20:463\u20137.","journal-title":"No Socchu No Geka"},{"key":"318_CR21","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1161\/01.STR.30.11.2272","volume":"30","author":"Y Yoshida","year":"1999","unstructured":"Yoshida Y, Yoshimoto T, Shirane RS, et al. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-up study. Stroke. 1999;30:2272\u20136.","journal-title":"Stroke."},{"issue":"5","key":"318_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/STROKEAHA.113.004386","volume":"45","author":"S Miyamoto","year":"2014","unstructured":"Miyamoto S, Yoshimoto T, Hashimoto N, et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014;45(5):1415\u201321.","journal-title":"Stroke"},{"key":"318_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3345\/kjp.2012.55.11.408","volume":"55","author":"KC Wang","year":"2012","unstructured":"Wang KC, Phi JH, Lee JY, Kim SK, Cho BK. Indirect revascularization surgery for moyamoya disease in children and its special considerations. Korean J Pediatr. 2012;55:408\u201313.","journal-title":"Korean J Pediatr"},{"key":"318_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ana.21981","volume":"68","author":"SK Kim","year":"2010","unstructured":"Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al. Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol. 2010;68:92\u2013101.","journal-title":"Ann Neurol"},{"key":"318_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.surneu.2006.07.017","volume":"67","author":"M Fujimura","year":"2007","unstructured":"Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol. 2007;67:273\u201382.","journal-title":"Surg Neurol"},{"key":"318_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1227\/NEU.0b013e318208f1da","volume":"68","author":"M Fujimura","year":"2011","unstructured":"Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery. 2011;68:957\u201364.","journal-title":"Neurosurgery"},{"issue":"3","key":"318_CR27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3171\/2014.10.JNS141426","volume":"123","author":"NR Gonzalez","year":"2015","unstructured":"Gonzalez NR, Dusick JR, Connolly M, et al. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations. J Neurosurg. 2015;123(3):654\u201361.","journal-title":"J Neurosurg"},{"key":"318_CR28","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/j.wneu.2018.04.076","volume":"115","author":"XY Bao","year":"2018","unstructured":"Bao XY, Zhang Y, Wang QN, Zhang Q, Wang H, et al. Long-term outcomes after Encephaloduroarteriosynangiosis in adult moyamoya disease patients presenting with Ischemia. World Neurosurg. 2018;115:e482\u20139.","journal-title":"World Neurosurg"},{"key":"318_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3171\/2014.1.JNS13946","volume":"121","author":"K Kazumata","year":"2014","unstructured":"Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, et al. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg. 2014;121:432\u201340.","journal-title":"J Neurosurg"},{"key":"318_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.wneu.2016.04.083","volume":"92","author":"H Sun","year":"2016","unstructured":"Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P, et al. Perioperative complications and long term outcomes after bypasses in adults with moyamoya disease: a systematic review and metaanalysis. World Neurosurg. 2016;92:179\u201388.","journal-title":"World Neurosurg"},{"key":"318_CR31","doi-asserted-by":"crossref","unstructured":"Macyszyn L, Attiah M, Ma TS, et al. Direct versus indirect revascularization procedures for moyamoya disease: a comparative effectiveness study. J Neurosurg. 2017;126(5):1523-1529.","DOI":"10.3171\/2015.8.JNS15504"},{"key":"318_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2176\/nmc.52.333","volume":"52","author":"DS Kim","year":"2012","unstructured":"Kim DS, Huh PW, Kim HS, Kim IS, Choi S, Mok JH, et al. Surgical treatment of moyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery. Neurol Med Chir (Tokyo). 2012;52:333\u20138.","journal-title":"Neurol Med Chir (Tokyo)"}],"container-title":["Chinese Neurosurgical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-023-00318-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41016-023-00318-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-023-00318-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:09:55Z","timestamp":1677143395000},"score":1,"resource":{"primary":{"URL":"https:\/\/cnjournal.biomedcentral.com\/articles\/10.1186\/s41016-023-00318-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1186\/s41016-023-00318-3","relation":{},"ISSN":["2057-4967"],"issn-type":[{"value":"2057-4967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"12 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}